Bridge Biotherapeutics (XKRX:288330) FCF Margin % : -350,337.16% (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Bridge Biotherapeutics's Free Cash Flow for the three months ended in Dec. 2024 was ₩-3,846.70 Mil. Bridge Biotherapeutics's Revenue for the three months ended in Dec. 2024 was ₩1.10 Mil. Therefore, Bridge Biotherapeutics's FCF Margin % for the quarter that ended in Dec. 2024 was -350,337.16%.

As of today, Bridge Biotherapeutics's current FCF Yield % is -10.22%.

The historical rank and industry rank for Bridge Biotherapeutics's FCF Margin % or its related term are showing as below:

XKRX:288330' s FCF Margin % Range Over the Past 10 Years
Min: -957533.1 Med: -1225.09 Max: -14.51
Current: -957533.1

During the past 9 years, the highest FCF Margin % of Bridge Biotherapeutics was -14.51%. The lowest was -957533.10%. And the median was -1225.09%.

XKRX:288330's FCF Margin % is ranked worse than
99.8% of 1005 companies
in the Biotechnology industry
Industry Median: -125.86 vs XKRX:288330: -957533.10

Bridge Biotherapeutics FCF Margin % Historical Data

The historical data trend for Bridge Biotherapeutics's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bridge Biotherapeutics FCF Margin % Chart

Bridge Biotherapeutics Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

FCF Margin %

Get a 7-Day Free Trial

-206.90

-1,106.81

-1,343.37

-32,144.19

-957,533.10

Bridge Biotherapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
FCF Margin %	Get a 7-Day Free Trial															-	-	-	-416,031.39	-350,337.16

Competitive Comparison of Bridge Biotherapeutics's FCF Margin %

For the Biotechnology subindustry, Bridge Biotherapeutics's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bridge Biotherapeutics's FCF Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Bridge Biotherapeutics's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Bridge Biotherapeutics's FCF Margin % falls into.

Save Embed

;

Save Embed

;

Bridge Biotherapeutics FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Bridge Biotherapeutics's FCF Margin for the fiscal year that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2024 )	/	Revenue (A: Dec. 2024 )
	=	-20855.071	/	2.178
	=	-957,533.10 %

Bridge Biotherapeutics's FCF Margin for the quarter that ended in Dec. 2024 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2024 )	/	Revenue (Q: Dec. 2024 )
	=	-3846.702	/	1.098
	=	-350,337.16 %

Bridge Biotherapeutics FCF Margin % Related Terms

Thank you for viewing the detailed overview of Bridge Biotherapeutics's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Bridge Biotherapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486

Website

http://www.bridgebiorx.com

Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.

Bridge Biotherapeutics Headlines

No Headlines